Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04608617 · ClinicalTrials.gov registry record
SYNCHRONISE: LVO Triage Timing and Outcome Study
A clinical trial, sponsored by Viz.ai.
- Completed
- Registry status
- 600
- Enrollment target
NCT04608617: Completed study, sponsored by Viz.ai.
NCT04608617 is a clinical trial that has completed, run by Viz.ai. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04608617 has completed, sponsored by Viz.ai.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the impact of Viz LVO in hospital systems with non-interventional and interventional (spoke and hub) stroke centers on the timing and outcomes of patients with suspected acute ischemic stroke indicated for mechanical thrombectomy.
Primary Outcome
Time in minutes from CT/CTA imaging to time leaving the spoke center
Interventions
- DEVICE Viz LVO (De Novo Number DEN170073)
- OTHER Baseline Effectiveness Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2023-04-26 |
What the finished NCT04608617 record still lists
NCT04608617 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Viz LVO (De Novo Number DEN170073) is the first listed.
NCT04608617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04608617 about?
NCT04608617 is a clinical study titled "SYNCHRONISE: LVO Triage Timing and Outcome Study". The objective of this study is to evaluate the impact of Viz LVO in hospital systems with non-interventional and interventional (spoke and hub) stroke centers on the timing and outcomes of patients with suspected acute ischemic stroke indicated for mechanical thrombectomy.
What is the current status of trial NCT04608617?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2021-03-09. Estimated completion is 2023-04-26.
What interventions are being tested in trial NCT04608617?
The interventions under investigation include: Viz LVO (De Novo Number DEN170073) (DEVICE), Baseline Effectiveness Cohort (OTHER).
Who is sponsoring clinical trial NCT04608617?
This trial is sponsored by Viz.ai, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI